Previous 10 | Next 10 |
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced...
NEW ORLEANS , March 27, 2020 /PRNewswire/ -- Former Attorney General of Louisiana , Charles C. Foti, Jr., Esq. , a partner at the law firm of Kahn Swick & Foti, LLC ("KSF"), announces that KSF has commenced an investigation into Apyx Medical Corporation (NasdaqGS: APYX). ...
SAN DIEGO, CA / ACCESSWIRE / March 17, 2020 / The Shareholders Foundation, Inc. announces that a that a lawsuit is pending for certain investors in Apyx Medical Corporation (NASDAQ:APYX) shares. Investors, who purchased shares of Apyx Medical Corporation (NASDAQ:APYX), have certain options ...
Image source: The Motley Fool. Apyx Medical Corp (NASDAQ: APYX) Q4 2019 Earnings Call Mar 16, 2020 , 5:00 p.m. ET Operator Continue reading
Apyx Medical Corporation (APYX) Q4 2019 Earnings Conference Call March 16, 2020 5:00 P.M. ET Company Participants Charles Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matthew Hewitt - Craig-Hallum Capital Gro...
Apyx Medical (NASDAQ: APYX ): Q4 GAAP EPS of -$0.16 beats by $0.03 . More news on: Apyx Medical Corporation, Earnings news and commentary, Healthcare stocks news, , Read more ...
Advanced Energy Sales increase 58% year-over-year in Q4 and increase 73% year-over-year in FY'19 Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvio...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Apyx Medical Corporation (NasdaqGS: APYX). On December 21, 2018, the Company announced th...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical (NASDAQ: APYX) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares...
Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion ® , today reported financial results for its first quarter ended March 31, 202...